Literature DB >> 1379349

Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups.

T A Reader1, E Molina-Holgado, L Lima, S Boulianne, K M Dewar.   

Abstract

Receptor binding studies were performed in rabbit neostriatum (caudate-putamen) using the dopamine D2 antagonist [3H]raclopride. Treatment of the membrane preparations with the reducing agent L-dithiothreitol (L-DTT) as well as with the alkylating compound N-ethylmaleimide (NEM), produced dose-dependent decreases of specific [3H]raclopride binding; the IC50 values were of 3.1 and 1.2 mM, respectively. Saturation experiments showed that the reduction of disulfide (-S-S-) bonds by L-DTT (1 mM) decreased the number of binding sites, with only a slight increase in the affinity. On the other hand, alkylation of sulfhydryl (-SH) groups by NEM (1 mM) decreased both receptor number and affinity. The properties of the remaining binding sites were examined in competition curves with the physiological substrate dopamine and the dopaminergic antagonist (+)butaclamol. The IC50 values for (+)butaclamol in control and in L-DTT and NEM treated membranes were between 3.4 and 4.8 nM, with Hill coefficients (nH) of 1, indicating that the remaining binding sites conserved a high affinity for antagonist binding. In the case of dopamine, the curves were shallow (nH 0.45-0.64) and both compounds increased the IC50 from 0.7 microM (control) to 8 microM and 11 microM, for L-DTT and NEM respectively. Iterative analysis revealed that L-DTT produced a very important (greater than 60%) decrease in the number of high-affinity (RH) binding. After NEM, there was a decrease in both the number of (RH) and the affinity (KH) of the high-affinity binding sites, and in the affinity (KL) of the low-affinity sites. These results demonstrate the participation of -S-S- and -SH groups in the agonist conformation of the primary ligand recognition site of the dopamine D2 receptor. Alternatively, -S-S- and -SH groups could be related to the coupling of the primary ligand recognition protein with adenylate cyclase by means of an inhibitory type of G protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379349     DOI: 10.1007/bf00969008

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupled beta-adrenergic receptors.

Authors:  J M Stadel; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

2.  Fat cell beta 1-adrenergic receptor: structural evidence for existence of disulfide bridges essential for ligand binding.

Authors:  C P Moxham; C C Malbon
Journal:  Biochemistry       Date:  1985-10-22       Impact factor: 3.162

3.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

4.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

5.  Sodium and potassium regulation of guanine nucleotide-stimulated adenylate cyclase in brain.

Authors:  R S Duman; R Z Terwilliger; E J Nestler; J F Tallman
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

6.  Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride.

Authors:  T A Reader; S Boulianne; E Molina-Holgado; K M Dewar
Journal:  Biochem Pharmacol       Date:  1990-10-15       Impact factor: 5.858

7.  Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.

Authors:  C Braestrup; P H Andersen
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

8.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.

Authors:  R K Sunahara; H B Niznik; D M Weiner; T M Stormann; M R Brann; J L Kennedy; J E Gelernter; R Rozmahel; Y L Yang; Y Israel
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

9.  Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.

Authors:  K M Dewar; B Montreuil; L Grondin; T A Reader
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

10.  Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: role of disulfide and sulfhydryl groups.

Authors:  T A Reader; R Brière; L Grondin
Journal:  Neurochem Res       Date:  1986-01       Impact factor: 3.996

View more
  1 in total

1.  Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling.

Authors:  Jaehoon Jeong; Young-Un Park; Dae-Kyum Kim; Saebom Lee; Yongdo Kwak; Seol-Ae Lee; Haeryun Lee; Yoo-Hun Suh; Yong Song Gho; Daehee Hwang; Sang Ki Park
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.